Regulatory T cells (Tregs) control organ-specific autoimmunity in a tissue antigen-specific manner, yet little is known about their specificity in a natural repertoire. In this study, we used the nonobese diabetic (NOD) mouse model of autoimmune diabetes to investigate the antigen specificity of Tregs present in the inflamed tissue, the islets of Langerhans. Compared with Tregs present in spleen and lymph node, Tregs in the islets showed evidence of antigen stimulation that correlated with higher proliferation and expression of activation markers CD103, ICOS, and TIGIT. T cell receptor (TCR) repertoire profiling demonstrated that islet Treg clonotypes are expanded in the islets, suggesting localized antigen-driven expansion in inflamed islets. To determine their specificity, we captured TCRαβ pairs from islet Tregs using single-cell TCR sequencing and found direct evidence that some of these TCRs were specific for islet-derived antigens including insulin B:9-23 and proinsulin. Consistently, insulin B:9-23 tetramers readily detected insulin-specific Tregs in the islets of NOD mice. Lastly, islet Tregs from prediabetic NOD mice were effective at preventing diabetes in Treg-deficient NOD.CD28
−/− recipients. These results provide a glimpse into the specificities of Tregs in a natural repertoire that are crucial for opposing the progression of autoimmune diabetes. + Foxp3 + regulatory T cells (Tregs) are essential in preventing autoimmunity in mice and humans (1, 2) . T cell receptor (TCR) signaling is essential for Treg development, homeostasis, and function. Tregs are thought to be predominantly specific for self-antigens (3) . Exposure to self-antigens in the thymus during T cell development can drive the development of thymic Tregs (4-8), whereas noninflammatory exposure to self-antigens in the periphery can induce mature conventional T (Tconv) cells to differentiate into peripheral Tregs (9) (10) (11) . In the periphery, Tregs are continuously stimulated by antigens, as evidenced by their dependence on CD28 costimulation to maintain peripheral homeostasis and proliferation in the steady state (12, 13) . Further supporting this notion, Tregs have high basal expression of the orphan nuclear receptor and immediate-early gene, Nur77, largely as a consequence of TCR signaling (14, 15) . TCR stimulation activates Tregs to exert their suppressive effects in vitro (16) . Similarly, Tregs specific for antigens expressed in target organs are more effective at controlling organ-specific autoimmune diseases in vivo (17) (18) (19) (20) . Ablation of TCR from Tregs leads to changes in Treg gene signature and impairment of Treg function (21, 22) . Collectively, these findings demonstrate the importance of antigen stimulation of Tregs in maintaining normal immune homeostasis. However, the exact antigen specificities of Tregs in most settings have not been defined.
The nonobese diabetic (NOD) mouse spontaneously develops an autoimmune attack against the islets of Langerhans (23) . The destructive inflammation is primarily driven by autoreactive T cells that are specific for a diverse array of islet beta cell antigens (24) .
Antigen specificities of these diabetogenic T cells include insulin, islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), glutamic acid decarboxylase (GAD), zinc transporter 8 (ZnT8), insulinoma antigen 2 (IA-2), phogrin (IA-2β), chromogranin, and islet amyloid polypeptide (IAPP) (25, 26) . These specificities likely arise from inefficient deletion of autoreactive T cells during thymic development and creation of neoantigen in the islets from posttranslational modifications such as hybrid insulin peptide (HIP) formation (27) (28) (29) (30) .
Despite progress in mapping the specificity of diabetogenic T cells, specificities of Tregs that control the progression of diabetes have not been determined. The challenge in determining Treg specificity is partly due to the rarity of islet antigen-specific Tregs in a natural highly diverse Treg repertoire. This is compounded by the difficulty in measuring Treg function in diabetes protection in vivo. Several published Treg repertoire studies used mice with a transgenic TCRβ chain to experimentally restrict T cell repertoire for easier identification of Treg antigen specificity. This practical approach is effective in tracking Treg clonotypes enriched in the colons and in prostate tumors (31) (32) (33) . However, a normal T cell repertoire of a mouse uses more than 5 × 10 5 distinct TCRβ chains (34) . Thus, the T cell repertoire in a mouse with fixed TCRβ chain is severely skewed, and Treg clonotypes found in these mice may not reflect those in a normal immune repertoire.
In this study, we set out to map the natural TCR repertoire and specificities of Tregs that protect against diabetes in NOD
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We then used the NOD.Nur77
GFP .Foxp3 RFP mice to identify Tregs with more recent islet antigen exposure. We compared GFP expression in Tregs from pancreatic LN (pancLN) and inflamed islets to those from spleen. Tregs from islets had the highest expression of Nur77 GFP compared with those from pancLN and spleen (Fig. 1A) . A subset of Tregs in the inflamed islets coexpressed previously reported TCR-dependent activation markers CD103, TIGIT, and ICOS (21) Statistical significance was determined using a repeated measures one-way ANOVA followed by Tukey's multiple comparison test; ***P < 0.001; ****P < 0.0001. (D) CD5 MFI in CD103 + or CD103 − Tregs from prediabetic NOD mice. Results shown are a summary of two independent experiments. Statistical significance was determined using a repeated measures one-way ANOVA followed by Tukey's multiple comparison test; **P < 0.01; ***P < 0.001; ns, not significant. (E) Ki67 staining in CD103 + or CD103 − Tregs from prediabetic NOD mice. Results shown are a summary of three independent experiments. Statistical significance was determined using a repeated measures one-way ANOVA followed by Tukey's multiple comparison test; **P < 0.01; ***P < 0.001; ns, not significant. (F) BrdU staining in CD103 + or CD103 − Tregs from prediabetic NOD mice. BrdU was administered continuously for 1 wk before analysis. Results shown are a summary of two independent experiments. Statistical significance was determined using a paired t test; *P < 0.05; ns, not significant. GFP high and low fractions ( Fig. 2A) . Between 1,600 and 600,000 Tregs were analyzed from different compartments, and 1,144 to 62,604 unique TCRβ sequences were identified (SI Appendix, Table S1 ). We used the clonality index-the inverse of normalized Shannon's entropy-to quantify the clonal dominance in each population, with 0 indicating that each clone appears only once and 1 representing a monoclonal population. While all Treg populations showed polyclonality, with a diversity index of less than 0.4, the CD103 + islet Tregs were the least diverse (Fig. 2B) . Clonal dominance can also be visualized by the contribution of the top 10 clones to the repertoire they reside in, which was 30% for CD103+ islet Tregs, markedly higher than the CD103 − islet Treg subsets ( Fig. 2 C and  D) . CD103
− Tregs in spleen, pancLN, and iLN were highly diverse, with the 10 most abundant clones representing less than 2% of the population (Fig. 2D) . These results further support local clonal expansion of activated Tregs in the inflamed islets.
Islet Antigen Specificity of Islet Tregs. Our results thus far suggest that Tregs specific to islet autoantigens are locally activated, clonally expand, and accumulate in the islets. However, distinct TCRs may recognize the same antigen. To further determine the specificity of islet Tregs, we performed single-cell sequencing of paired TCRαβ chains and then further interrogated for their specificity using an in vitro reporter assay (39, 40) . FACSpurified ICOS + TIGIT + islet Tregs, which also express high levels of CD103 and Nur77 GFP (SI Appendix, Fig. S2A ), were sorted into single wells for barcoding and sequencing. Among the 71 paired TCRαβ sequences identified, six TCRs were found more than once in a single mouse, indicating clonal expansion, and two other TCRs were found in multiple mice (SI Appendix, Table S2 ). We thus selected these eight TCRs for further analysis of their reactivity to islet antigens.
We reconstituted the paired TCRs using retroviral transduction in a hybridoma cell line that expresses an NFAT GFP reporter construct so that TCR triggering can be measured by GFP expression. A hen egg lysosome (HEL)-specific TCR (PA21.14H4) was used as a negative control, and a TCR for insulin (p3w17) was used as a positive control in the screening. We stimulated all TCRtransduced hybridomas with splenic CD11c + dendritic cells (DCs) pulsed with lysate from NOD.Rag2 −/− islets. Five of eight clones (i.e., 510, 518, 521, 550, and 551) showed measurable reactivity to islet lysates (Fig. 3A) . To determine whether these TCRs respond to islet antigen naturally processed and presented by DCs in the inflamed islets, we stimulated the hybridomas with freshly isolated islet-derived CD11c + DCs. In this assay, the same five clones responded to islet DCs, but not to control DCs from spleen or colon (Fig. 3 A and B and SI Appendix, Fig. S3B ). To further map antigen specificity of these TCRs, we screened the hybridomas against 19 peptides previously reported to be stimulatory to islet antigen-specific CD4 + T cells in NOD mice (SI Appendix, Table  S3 ). None of the TCRs responded to BDC mimotopes, HIPs, or peptides from ZnT8, GAD, IGRP, IAPP, or IA-2β (SI Appendix, Table S3 ).
Insulin is a dominant autoantigen in type 1 diabetes in both NOD mice and human patients (41, 42 ). Therefore, we tested Treg TCRs against insulin. One TCR, 521, responded to splenic DCs loaded with insulin B:9-23 peptide (Fig. 3C and Table 1 ). Another TCR, 510, responded to immobilized insulin B:9-23 p8E and p8G tetramers (29) (Fig. 3C and Table 1 ). To determine reactivity to other insulin epitopes, we stimulated the hybridomas with splenic DCs pulsed with metabolically inactive human insulin, B25D-insulin (43) . The use of B25D-insulin avoided the hormonal activation of the hybridomas that altered the assay background. TCR 551 responded to B25D-insulin ( Fig. 3C and Table 1 ). Additionally, we found that TCR 518 responded to a previously described proinsulin peptide, insulin B:24-36 ( Fig. 3C and Table  1 ) (44) . The remaining islet antigen-specific TCR, 550, did not respond to any of the above insulin stimulations (Fig. 3C , Table 1 , and SI Appendix, Table S3 ). In summary, five of eight islet Tregderived TCRs were stimulated by islet antigens, and four of the five were specific for insulin (Table 1) .
Insulin Specificity Among Islet Tregs. Our results suggest that insulin specificity may be common among islet-infiltrating Tregs.
To further test this notion, we analyzed Tregs and Tconv cells in islets and pancLN of NOD mice (8 to 28 wk old) using insulin I-A g7 tetramer containing modified insulin B:9-23 peptides p8E and p8G (29) . Insulin B:9-23-specific cells were readily detectable among islet Treg and Tconv cells but were not consistently found in the pancLN (SI Appendix, Fig. S4 ). Insulin B:9-23-specific islet Tregs were often present at higher frequencies than insulin B:9-23-specific Tconv cells in prediabetic mice (Fig. 4B) . Overall, the total numbers of insulin-specific Tconv cells per islet were slightly higher than the total number of insulin-specific Tregs (Fig. 4C) . Moreover, insulin tetramer-positive Tregs had higher Nur77
GFP expression than insulin tetramer-negative Tregs, indicating stronger TCR activation (Fig. 4D) . Thus, the insulin tetramer stain result is consistent with single-cell TCR sequencing analysis and shows that a demonstrable proportion of islet Tregs is insulin specific.
Function of Islet Tregs. Islet antigen-specific Tregs are more effective at protecting against diabetes (17, 18) . Given their islet antigen specificity and propensity to be activated in the islets, we hypothesized that islet Tregs in the NOD mice would be effective at suppressing diabetes. We assessed the in vivo capacity of islet Tregs to prevent diabetes in an adoptive transfer model using NOD.CD28 −/− mice as recipients. These mice develop diabetes at a younger age and at higher penetrance due to Treg defects (12, 13). More than 80% of NOD.CD28 −/− mice become diabetic between 8 and 12 wk of age, which can be largely prevented by adoptive transfer of 50,000 islet antigen-specific Tregs from BDC-2.5 TCR transgenic mice (Fig. 5A) . The same dose of Tregs isolated from spleen, pancLN, or nonpancreas draining LNs (mesenteric LN and inguinal LN) of prediabetic NOD mice were unable to prevent diabetes (Fig. 5B) . Transfer of 50,000 islet Tregs prevented diabetes as efficiently as BDC-2.5 Tregs (Fig. 5C) . Taken together, this study demonstrates that inflamed islets contain an enrichment of islet antigen-specific Tregs that exhibit potent antidiabetes activity.
Discussion
Collectively, results from this study show that islet antigenspecific (particularly insulin-specific) Tregs are enriched in the inflamed islets of NOD mice. These Tregs are functional in curbing the progression of islet destruction. It is worth noting that most NOD mice eventually succumb to diabetes, likely because islet antigen-specific Tregs die due to IL-2 deficiency in inflamed islets and exhaustion of the islet antigen-specific Treg pool from chronic attrition (45) .
Insulin is the most abundant protein in beta cells and a key autoantigen for driving the initiation and progression of autoimmune beta cell destruction (42, 46, 47) . In this study, we found a prominence of insulin-specific Tregs in inflamed islets. A recent study has reported that human subjects with long-standing antiislet autoimmunity without progression to overt diabetes have increased frequency of insulin-specific Tregs compared to healthy subjects and those with diabetes onset at a young age (48) . These results suggest an important role for insulin-specific Tregs in controlling diabetes progression. To our surprise, none of the TCRs responded to any of the 19 peptides previously reported to stimulate islet antigen-specific CD4 + T cells. Previous analyses used CD4 + T cells and likely did not include many Treg clones. Moreover, the Treg clone analysis in this report is limited and aimed only at identifying dominant clones. Nonetheless, the two insulin epitopes we are able to identify in this study have been previously reported for Tconv cells. Overall, our mapping of Treg specificities in the inflamed islets suggest insulin as a dominant specificity and that insulinspecific Tregs and Tconv cells can recognize the same epitopes.
The prominent and highly localized presence of insulin-specific Tregs in inflamed islets is somewhat unexpected. Insulin is a systemic hormone that can potentially be presented by DCs throughout the body. However, insulin-specific T cells are hard to detect outside islets, and insulin-specific TCRs were not activated by splenic DCs in vitro without addition of islet antigens or insulin peptides. These results suggest that insulin-specific Tregs likely require high abundance of insulin to be activated, which limits their suppressive activity to the islets at the source of insulin production. This observation has important implications for developing islet antigen-specific Treg therapies. Polyclonal Treg therapy is being evaluated in patients with type 1 diabetes in early-phase clinical trials (49, 50) . Genetic engineering of Tregs with TCR-specific islet antigens has the potential to increase therapeutic efficacy and minimize systemic immunosuppression. A key issue in engineering TCRs for islet antigen-specific Tregs is to ensure that the targeted antigens are naturally presented at adequate levels in the islets and draining LN to activate the engineered Tregs. Our results suggest that insulin-specific TCRs are viable candidates for engineering Treg specificity for the protection of beta cells.
Materials and Methods
Bulk TCRβ Sequencing. Total RNA was extracted from FACS-purified Tregs using ARCTURUS PicoPure RNA Isolation Kit (Life Technologies) for <100,000 cells or a microRNA extraction kit (QIAGEN) for >100,000 cells. TCRβ repertoires were amplified and sequenced using Illumina MiSeq by iRepertoire, Inc. Data analysis was performed using iRepertoire, Inc. web tools (https://www.irepertoire.com). Clonality was calculated using the inverse of normalized Shannon's diversity index.
Single-Cell TCRαβ Sequencing. Individual activated islet Tregs were flow sorted into single wells of a 96-well plate, and TCR sequences from single cells were obtained using three rounds of PCR to amplify and barcode before sequencing on an Illumina MiSeq as previously described (39, 40) .
Hybridoma Assays. Splenic and islet DCs were enriched using a CD11c Insulin Tetramer Staining. The APC-conjugated tetramer of I-A g7 bound to insulin B:9-23 mimotopes p8E (HLVERLYLVCGEEG) and p8G (HLVERLYLVCGGEG) (29) and HEL (AMKRHGLDNYRGYSL) were obtained from the National Institutes of Health Tetramer Core Facility at Emory University and stained for 2 h at 37°C for pancLN and islet T cell analysis.
Mice. All experiments involving mice have been approved by the Institutional Animal Care and Use Committee at the University of California, San Francisco.
Statistical Analysis. Analyses were performed with GraphPad Prism (GraphPad Software) as detailed in the figure legends.
Additional information can be found in SI Appendix, Supplemental Experimental Procedures.
